Barry H. Levine

596 total citations
15 papers, 437 citations indexed

About

Barry H. Levine is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Barry H. Levine has authored 15 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Barry H. Levine's work include Melanoma and MAPK Pathways (5 papers), Heart Failure Treatment and Management (3 papers) and Chemical Synthesis and Analysis (2 papers). Barry H. Levine is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Heart Failure Treatment and Management (3 papers) and Chemical Synthesis and Analysis (2 papers). Barry H. Levine collaborates with scholars based in United States, Switzerland and France. Barry H. Levine's co-authors include Roger A. Rennels, John M. Nuss, Thomas W von Geldern, Paul A. Wender, Euan Murray, Savithri Ramurthy, Sharadha Subramanian, Cynthia M. Shafer, James W. Young and Abran Costales and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Barry H. Levine

15 papers receiving 407 citations

Peers

Countries citing papers authored by Barry H. Levine

Since Specialization

Citations

This map shows the geographic impact of Barry H. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barry H. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barry H. Levine more than expected).

Fields of papers citing papers by Barry H. Levine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barry H. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barry H. Levine. The network helps show where Barry H. Levine may publish in the future.

Co-authorship network of co-authors of Barry H. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of Barry H. Levine. A scholar is included among the top collaborators of Barry H. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barry H. Levine. Barry H. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors 2019 ·Bioorganic & Medicinal Chemistry Letters ·Savithri Ramurthy, Keith Pfister, (unknown), Sean P. Brown, (unknown), Manoj C. Desai, Eric Fang, Barry H. Levine, Simon C. Ng, John M. Nuss, David B. Ring, Cynthia M. Shafer, Wei Shu, Sharadha Subramanian, Allan S. Wagman, Haixia Wang, Dirksen E. Bussiere	11
2	Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma 2015 ·ACS Medicinal Chemistry Letters ·(unknown), Sharadha Subramanian, Joelle Verhagen, Christopher M. McBride, Abran Costales, (unknown), (unknown), (unknown), (unknown), Savithri Ramurthy, Barry H. Levine, Cynthia M. Shafer, Timothy Machajewski, Paul A. Renhowe, B.A. Appleton, Payman Amiri, James Chou, Darrin D. Stuart, Kimberly Aardalen, Daniel Poon	35
3	Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors 2014 ·ACS Medicinal Chemistry Letters ·Sharadha Subramanian, Abran Costales, (unknown), Barry H. Levine, Christopher M. McBride, Daniel Poon, Payman Amiri, Paul A. Renhowe, Cynthia M. Shafer, Darrin D. Stuart, Joelle Verhagen, Savithri Ramurthy	11
4	Design and synthesis of 6,6-fused heterocyclic amides as raf kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Savithri Ramurthy, Abran Costales, Johanna M. Jansen, Barry H. Levine, Paul A. Renhowe, Cynthia M. Shafer, Sharadha Subramanian	17
5	Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors 2008 ·Journal of Medicinal Chemistry ·Savithri Ramurthy, Sharadha Subramanian, Mina Aikawa, Payman Amiri, Abran Costales, (unknown), Susan Fong, Johanna M. Jansen, Barry H. Levine, Sylvia Ma, Christopher M. McBride, (unknown), Teresa E. Pick, Daniel J. Poon, Sandhya Girish, Cynthia M. Shafer, Darrin D. Stuart, (unknown), Paul A. Renhowe	72
6	CHIR-265 is a potent selective inhibitor of c-Raf/B-Raf/mutB-Raf that effectively inhibits proliferation and survival of cancer cell lines with Ras/Raf pathway mutations 2006 ·Cancer Research ·Payman Amiri, Mina Aikawa, (unknown), Darrin D. Stuart, Daniel Poon, (unknown), Savithri Ramurthy, Sharadha Subramanian, Barry H. Levine, Abran Costales, Alex L. Harris, (unknown)	18
7	Preclinical toxicity studies of kahalalide F, a new anticancer agent: single and multiple dosing regimens in the rat 2002 ·Cancer Chemotherapy and Pharmacology ·Alan Brown, (unknown), Glynn Faircloth, Barry H. Levine	23
8	New submonomers for poly N-substituted glycines (peptoids) 1999 ·Tetrahedron Letters ·Tetsuo Uno, Eric Beausoleil, Richard Goldsmith, Barry H. Levine, Ronald N. Zuckermann	42
9	Endogenous natriuretic factors 3: isolation and characterization of human natriuretic factors llu-α, LLU-β1, and llu-γ 1995 ·Life Sciences ·Euan Murray, Darko Kantoci, (unknown), (unknown), Derin C. D’Amico, James G. King, (unknown), Barry H. Levine, Michael E. Jung, William J. Wechter	16
10	Rac‐Flurbiprofen is more ulcerogenic than its (S)‐enantiomer 1993 ·Chirality ·(unknown), (unknown), Euan Murray, Barry H. Levine, James W. Young	49
11	Endogenous natriuretic factors. 2: Characterization of natriuretic and vasopressive substances from human uremic urine. 1993 ·PubMed ·Barry H. Levine, Euan Murray, (unknown), (unknown), William J. Wechter	4
12	Transition-metal-catalyzed strategies for the synthesis of neocarzinostatin chromophore and analogs: intramolecular delivery of palladium controls construction of the biologically relevant dienediyne core 1993 ·Journal of the American Chemical Society ·John M. Nuss, Roger A. Rennels, Barry H. Levine	43
13	Endogenous Natriuretic Factors 2 1993 ·Journal of Cardiovascular Pharmacology ·Barry H. Levine, (unknown), (unknown), (unknown), William J. Wechter	4
14	An approach to the A ring of neocarzinostatin chromophore via sequential carbometalation/anion capture 1991 ·Tetrahedron Letters ·John M. Nuss, Barry H. Levine, Roger A. Rennels, Majid M. Heravı	34
15	Synthetic studies on arene-olefin cycloadditions. 10. A concise, stereocontrolled total synthesis of (.+-.)-laurenene 1988 ·Journal of the American Chemical Society ·Paul A. Wender, Thomas W von Geldern, Barry H. Levine	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact